Investing.com · 2026-10-22
Ionis Pharmaceuticals stock price target maintained at $100 by H.C. Wainwright on HBV approval Investing.com
Sector coverage: Healthcare · Biotechnology
Read the original at Investing.com ↗
Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.
Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。